Latest Refinancing News

Chrysos Corporation posted a 33% revenue increase and 68% EBITDA growth in FY26, driven by expanding its PhotonAssay™ technology fleet to 46 units worldwide and signing 24 new lease agreements.

Centuria Industrial REIT (ASX:CIP) reported a 20.5% jump in net profit to $160.4 million for FY26, underpinned by strong leasing activity, premium asset divestments, and advancing data centre initiatives.

Southern Cross Media Group’s FY26 results reveal a 4.5% revenue drop amid a soft advertising market, but $30 million in merger synergies delivered a year early and digital revenue growth offer a silver lining.

CAR Group Limited reported a 14% increase in net profit after tax to AUD 332.4 million for FY26, driven by strong revenue growth and AI innovation across its global vehicle marketplaces.

Locality Planning Energy has consolidated its debt into a $7.2 million Westpac facility, lowering borrowing costs and freeing capital to back a $5.8 million development pipeline.

Charter Hall Retail REIT's FY26 statutory profit soared 78% to $389.4 million, driven by a $305 million portfolio valuation uplift and a strategic pivot to convenience net lease retail assets. Distributions rose 3.3% amid a debt refinancing that lowered margins and extended maturities.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

Centuria Office REIT swung to a $55.2 million profit in FY26, driven by solid leasing activity and a $1 billion debt refinancing that extended maturities and cut margins. The REIT maintained stable occupancy and delivered distributions in line with guidance, while setting a positive outlook for FY27.

Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.

Livium Ltd has locked in A$1.575 million in initial funding from The Lind Partners, with potential to raise up to A$11.75 million over two years, while offering shareholders a discounted share purchase plan to support its recycling growth strategy.

Mesoblast delivered US$115 million in Ryoncil® revenue in its first full year post-FDA approval, while expanding clinical trials into adult indications and acquiring cutting-edge CAR technology to boost its cell therapy pipeline.

Janus Electric navigated a transitional Q4 FY26 by settling legacy debts, raising $12 million, and growing its North American order book to 112 truck conversions, positioning itself for commercial scale-up.